o-chlorophentermine

Small moleculeexperimental

Clortermine hydrochloride (Voranil) is a non-amphetamine anorexigenic agent. Voranil, a sympathomimetic amine, is indicated for short-term adjunctive treatment of exogenous obesity. Its long duration of action permits once-a-day dosage. In a large number of patients studied, Voranil was found to be superior to placebo in weight reduction. Insomnia, dry mouth, palpitations and tachycardia have been reported in a small percentage of patients taking the drug. Voranil was originally developed by Ciba Pharmaceuticals Corporation and transferred to USV Pharmaceuticals Corporation in December 1971, as a result of a product exchange agreement. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Indications

Approved for

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)(N)Cc1ccccc1Cl
Mol. weight
183.68 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • chlortermine
  • clortermine
  • clortermine
  • clortermine hcl
  • clortermine hydrochloride
  • clortermine hydrochloride
  • clortermine hydrochloride
  • clortermine hydrochloride
  • clortermine hydrochloride
  • o-chlorophentermine